Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Members can think of this as their one-stop shop for GLP-1 medications and support
"We are committed to providing our patients the best treatments available and continually evaluate potential treatment options," a spokesperson wrote in an email
Importantly, people who are pregnant, breastfeeding, under 18 years of age, or who have a current or previous eating disorder should not use weight loss supplements unless specifically advised to do so by a clinician
Mechanisms of Action Retatrutide activates three key receptors to modulate energy balance, appetite, and metabolism, leading to profound weight loss and glycemic control.[1][2] This triple agonism differentiates it from dual agonists like tirzepatide, enhancing fat oxidation and insulin sensitivity.[3][10] Key sub-mechanisms include: GLP-1 Receptor Activation : Suppresses appetite, delays gastric emptying, and promotes insulin secretion in a glucose-dependent manner.[1][11] GIP Receptor Activation : Enhances insulinotropic effects and improves beta-cell function, contributing to postprandial glucose control.[2][12] Glucagon Receptor Activation : Increases energy expenditure, promotes lipolysis, and supports hepatic fat reduction without significant hyperglycemia.[1][13] Synergistic Metabolic Regulation : Combines receptor effects to amplify weight loss through reduced caloric intake and increased thermogenesis.[3][14] Cardiometabolic Protection : Improves lipid profiles and reduces inflammation via multi-pathway modulation.[4][15] These mechanisms highlight Retatrutide's potential for compounding in therapies targeting obesity and related comorbidities
References 1 Wu, G., Fang, Y.-Z., Yang, S., Lupton, J
By contrast, while PCSK1/3 mRNA increases in patients with diabetes compared to healthy individuals, the density of PC1/3-positive cells decreases (Jorsal et al., 2018), suggesting a posttranslational impact on GLP-1 availability
